SCHEMBL4540902

SCHEMBL4540902

FC(Cc1c(CCNc2ncnc3[nH]cnc23)ncc2c(Cl)cccc12)N1CCOCC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.35
CYP3A4 P08684 4/20 0.35
CYP2D6 P10635 4/20 0.35
TSHR P16473 4/20 0.35
LMNA P02545 3/20 0.35
CYP2C19 P33261 2/20 0.35
HIF1A Q16665 2/20 0.35
ALDH1A1 P00352 6/20 0.35
MAPK1 P28482 3/20 0.34
CLK4 Q9HAZ1 3/20 0.34
USP2 O75604 1/20 0.34
ADK P55263 1/20 0.33
KDM4E B2RXH2 3/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
POLB P06746 1/20 0.33
P2RX7 Q99572 4/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
HPGD P15428 2/20 0.32
HSD17B10 Q99714 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4540900 0.72 ALDH1A1 (0.40) CYP1A2CYP3A4CYP2D6TSHRLMNA
SCHEMBL4541336 0.69 ADK (0.33) CYP1A2CYP3A4CYP2D6LMNAALDH1A1
SCHEMBL4923979 0.64 LMNA (0.48) CYP1A2CYP3A4CYP2D6TSHRLMNA
SCHEMBL4541331 0.64 LRRK2 (0.40) CYP1A2CYP3A4CYP2D6TSHRLMNA
SCHEMBL2019257 0.64 LMNA (0.41) LMNAMAPK1CLK4SMN1; SMN2HTT
SCHEMBL4926047 0.63 ALDH1A1 (0.47) TSHRLMNAALDH1A1MAPK1KDM4E
SCHEMBL3701676 0.63 PIK3CD (0.46) CYP1A2CYP3A4CYP2D6MAPK1CLK4
SCHEMBL3701674 0.63 PIK3CD (0.46) CYP1A2CYP3A4CYP2D6MAPK1CLK4
SCHEMBL2717143 0.63 MAP4K4 (0.41) LMNAMAPK1CLK4SMN1; SMN2HTT
SCHEMBL9960486 0.62 EGFR (0.40) CYP1A2CYP3A4CYP2D6TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2637669-A2 HETEROCYCLIC COMPOUNDS AND USES THEREOF Infinity Pharmaceuticals, Inc. (US) 2013-09-18 EP disclosed
WO-2012064973-A2 HETEROCYCLIC COMPOUNDS AND USES THEREOF INFINITY PHARMACEUTICALS, INC. (US) 2012-05-18 WO disclosed